Recommandations en Onco-Urologie 2010 : Cancer du rein

[1]  B. Lane,et al.  Sunitinib in patients (pts) with unresectable primary renal cell carcinoma (RCC). , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Ravaud,et al.  Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon‐α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial , 2011, BJU international.

[3]  A. Ravaud,et al.  Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Russo.  Multi-modal treatment for metastatic renal cancer: the role of surgery , 2010, World Journal of Urology.

[5]  J. Leppert,et al.  Comparison of accuracy of 14‐, 18‐ and 20‐G needles in ex‐vivo renal mass biopsy: a prospective, blinded study , 2010, BJU international.

[6]  Jihad H Kaouk,et al.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. , 2010, The Journal of urology.

[7]  E. Wallen,et al.  Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  I. Gill,et al.  Clinical practice. Small renal mass. , 2010, The New England journal of medicine.

[9]  K. Bensalah,et al.  Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. , 2010, European urology.

[10]  C. Sternberg,et al.  Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Patard,et al.  Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. , 2010, Urology.

[12]  A. Zisman,et al.  Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. , 2010, Urology.

[13]  H. Lang,et al.  Cancer du rein , 2010 .

[14]  E. Budtz-Jørgensen,et al.  Surveillance in von Hippel‐Lindau disease (vHL) , 2010, Clinical genetics.

[15]  Wanling Xie,et al.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Kavoussi,et al.  Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. , 2009, The Journal of urology.

[17]  G. Keating,et al.  Everolimus: in advanced renal cell carcinoma. , 2009, Drugs.

[18]  A. Kural,et al.  Robot-assisted partial nephrectomy versus laparoscopic partial nephrectomy: comparison of outcomes. , 2009, Journal of endourology.

[19]  W. Roberts,et al.  Patient and pathologic correlates with perioperative and long-term outcomes of laparoscopic radical nephrectomy. , 2009, Urology.

[20]  R. Millikan,et al.  Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Lifshitz,et al.  Laparoscopic partial nephrectomy: predictors of prolonged warm ischemia. , 2009, The Journal of urology.

[22]  U. Capitanio,et al.  Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma) , 2009, BJU international.

[23]  M. Stifelman,et al.  Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. , 2009, The Journal of urology.

[24]  P. Russo,et al.  Hereditary and familial kidney cancer. , 2009, Current opinion in urology.

[25]  E. Klein,et al.  Surgical resection of renal cell carcinoma after targeted therapy. , 2009, The Journal of urology.

[26]  S. Boorjian,et al.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance , 2009, Cancer.

[27]  B. K. Park,et al.  CT-Guided Radiofrequency Ablation of a Renal Tumor Abutting Vascular Pedicle in a Patient with von Hippel Lindau Disease , 2009, CardioVascular and Interventional Radiology.

[28]  L. Bostad,et al.  Observation should be considered as an alternative in management of renal masses in older and comorbid patients. , 2009, European urology.

[29]  L. Hertle,et al.  Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents , 2009, Expert review of anticancer therapy.

[30]  B. K. Park.  Re: Mesut Remzi, Michael Marberger. Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur urol 2009;55:359-67. , 2009, European urology.

[31]  S. Taneja,et al.  The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. , 2009, The Journal of urology.

[32]  F. Saad,et al.  Radical versus partial nephrectomy , 2009, Cancer.

[33]  J. Cheville,et al.  Tubulocystic Carcinoma of the Kidney: Clinicopathologic Analysis of 31 Cases of a Distinctive Rare Subtype of Renal Cell Carcinoma , 2009, The American journal of surgical pathology.

[34]  elliot k fishman,et al.  The role of surgery in the management of isolated metastases to the pancreas. , 2009, The Lancet. Oncology.

[35]  M. Remzi,et al.  Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? , 2009, European urology.

[36]  M. Pomoni,et al.  Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience. , 2009, European journal of radiology.

[37]  K. Bensalah,et al.  A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. , 2009, European urology.

[38]  J. Patard,et al.  Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. , 2009, Urology.

[39]  S. Bhayani,et al.  Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. , 2009, Urology.

[40]  C. Tangen,et al.  Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949. , 2009, The Journal of urology.

[41]  E. Klein,et al.  Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. , 2009, The Journal of urology.

[42]  Victoria Y. Bird,et al.  Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy. , 2009, Journal of endourology.

[43]  M. Soloway,et al.  The Increasing Use of Liver Transplantation Surgical Techniques in the Management of Renal and Nonrenal Cancer With or Without Inferior Vena Cava Tumor Thrombus , 2009, World Journal of Surgery.

[44]  B. Teh,et al.  Adult Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney Are the Same Disease Entity: Molecular and Histologic Evidence , 2009, The American journal of surgical pathology.

[45]  H. Moch,et al.  Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases , 2008, The American journal of surgical pathology.

[46]  J. Patard,et al.  Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma , 2008, BJU international.

[47]  R. Uzzo,et al.  Cryoablation or radiofrequency ablation of the small renal mass , 2008, Cancer.

[48]  Brian R Herts,et al.  Management of the incidental renal mass. , 2008, Radiology.

[49]  S. Silverman,et al.  Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. , 2008, Journal of vascular and interventional radiology : JVIR.

[50]  R. Motzer,et al.  Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial , 2008, The Lancet.

[51]  B. Lane,et al.  Active surveillance of renal masses in elderly patients. , 2008, The Journal of urology.

[52]  S. Nakada,et al.  Renal thermal ablative therapy. , 2008, The Urologic clinics of North America.

[53]  K. Marumo,et al.  Risk factors for ipsilateral adrenal involvement in renal cell carcinoma. , 2008, Urology.

[54]  R. Figlin,et al.  An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial , 2008, The Lancet.

[55]  M. Kattan,et al.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer. , 2008, The Journal of urology.

[56]  Paul Russo,et al.  Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. , 2008, The Journal of urology.

[57]  G. Haber,et al.  Laparoscopic partial nephrectomy versus laparoscopic cryoablation for multiple ipsilateral renal tumors. , 2008, European urology.

[58]  G. Haber,et al.  Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. , 2008, Urology.

[59]  A. Berkenblit,et al.  Exploratory analysis of the influence of nephrectomy status on temsirolimus efficacy in patients with advanced renal cell carcinoma and poor-risk features , 2008 .

[60]  C. Porta,et al.  Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC) , 2008 .

[61]  Mesut Remzi,et al.  Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. , 2008, European urology.

[62]  J. Haanen,et al.  Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response , 2008, Clinical Cancer Research.

[63]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[64]  J. Kaouk,et al.  Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. , 2008, The Journal of urology.

[65]  Ralf Seip,et al.  A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focused ultrasound. , 2008, European urology.

[66]  F. Porpiglia,et al.  Laparoscopic versus open partial nephrectomy: analysis of the current literature. , 2008, European urology.

[67]  A. Antonelli,et al.  Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm , 2008 .

[68]  M. Marberger,et al.  ENERGY ABLATIVE THERAPY OF SMALL RENAL TUMOURS BY LAPAROSCOPIC HIGH-INTENSITY FOCUSED ULTRASOUND , 2008 .

[69]  J. Patard,et al.  Prognostic factors and selection for clinical studies of patients with kidney cancer. , 2008, Critical reviews in oncology/hematology.

[70]  J. Kaouk,et al.  Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. , 2008, The Journal of urology.

[71]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[72]  J. Borin.  Laparoscopic radical nephrectomy: long-term outcomes , 2008, Current opinion in urology.

[73]  I. Gill,et al.  Halving ischemia time during laparoscopic partial nephrectomy. , 2008, The Journal of urology.

[74]  Stephen A Boorjian,et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[75]  M. Schonlau,et al.  Renal and cardiovascular morbidity after partial or radical nephrectomy , 2008, Cancer.

[76]  Bohuslav Melichar,et al.  Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial , 2007, The Lancet.

[77]  S. Joniau,et al.  Is surveillance an option for the treatment of small renal masses? , 2007, European urology.

[78]  Y. Neuzillet,et al.  Tumeurs du Rein , 2007 .

[79]  N. Shah,et al.  Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques. , 2007, European urology.

[80]  P. Karakiewicz,et al.  Predicting cancer-control outcomes in patients with renal cell carcinoma , 2007, Current opinion in urology.

[81]  Louis R Kavoussi,et al.  Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. , 2007, The Journal of urology.

[82]  J. Lam,et al.  Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection , 2007, Expert review of anticancer therapy.

[83]  B. Rini,et al.  The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy. , 2007, The Journal of urology.

[84]  R. Sylvester,et al.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2007, European urology.

[85]  David McDermott,et al.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. , 2007, The New England journal of medicine.

[86]  B. Leibovich,et al.  Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma , 2007, Current urology reports.

[87]  V. Margulis,et al.  Renal cell carcinoma clinically involving adjacent organs , 2007, Cancer.

[88]  P. Clark,et al.  Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study. , 2007, AJR. American journal of roentgenology.

[89]  S. Culine,et al.  Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. , 2007, The Journal of urology.

[90]  J. Patard,et al.  Multi-institutional validation of a new renal cancer-specific survival nomogram. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  A. Hemal,et al.  Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. , 2007, The Journal of urology.

[92]  R. Uzzo,et al.  Enhancing renal masses with zero net growth during active surveillance. , 2007, The Journal of urology.

[93]  É. Lechevallier.  Core Biopsy of Solid Renal Masses under CT Guidance , 2007 .

[94]  N. Rioux-Leclercq,et al.  Prognostic ability of simplified nuclear grading of renal cell carcinoma , 2007, Cancer.

[95]  R. Thompson,et al.  The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. , 2007, The Journal of urology.

[96]  B. K. Park,et al.  Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. , 2007, European journal of radiology.

[97]  S. Jung,et al.  Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. , 2007, Annals of diagnostic pathology.

[98]  A. Antonelli,et al.  The follow‐up management of non‐metastatic renal cell carcinoma: definition of a surveillance protocol , 2007, BJU international.

[99]  R. Figlin,et al.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. , 2007, The New England journal of medicine.

[100]  Apurva A Desai,et al.  Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.

[101]  J. Kaouk,et al.  Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. , 2006, The Journal of urology.

[102]  Andrew J Vickers,et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.

[103]  J. Hétet,et al.  Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s. , 2006, European urology.

[104]  K. Shiraishi,et al.  Laparoscopic decortication of symptomatic simple renal cysts: 10‐year experience from one institution , 2006 .

[105]  P. Russo,et al.  Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  Ralph V Clayman,et al.  Laparoscopic partial nephrectomy for renal masses: effect of tumor location. , 2006, Urology.

[107]  P. Russo,et al.  Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm , 2006, BJU international.

[108]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[109]  F. Guillé,et al.  Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. , 2006, European urology.

[110]  O. Hélénon,et al.  Traitement conservateur des cancers du rein par cryoablation et radiofréquence , 2006 .

[111]  M. Colombel,et al.  Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. , 2006, European urology.

[112]  M Ziegler,et al.  Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients. , 2006, European urology.

[113]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[114]  Robert Tibshirani,et al.  Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma , 2005, PLoS medicine.

[115]  Y. Neuzillet,et al.  Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. , 2005, Urology.

[116]  I. Gill,et al.  Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. , 2005, Urology.

[117]  Sunita Chauhan,et al.  Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. , 2005, Journal of endourology.

[118]  F. Guillé,et al.  Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy , 2005, Cancer.

[119]  G. Israel,et al.  An update of the Bosniak renal cyst classification system. , 2005, Urology.

[120]  J. Kaouk,et al.  Laparoscopic partial nephrectomy for cystic masses. , 2005, The Journal of urology.

[121]  L. Kavoussi,et al.  Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. , 2005, The Journal of urology.

[122]  A. Villers,et al.  Renal Cell Carcinoma Associated with Tumor Thrombus in the Inferior Vena Cava: Surgical Strategies , 2005, Annals of vascular surgery.

[123]  J. Kaouk,et al.  Renal cryoablation: outcome at 3 years. , 2005, The Journal of urology.

[124]  D. Grignon,et al.  Clear cell renal cell carcinoma. , 2005, Clinics in laboratory medicine.

[125]  P. Fornara,et al.  Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) , 2005, British Journal of Cancer.

[126]  E. Blackstone,et al.  Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? , 2005, The Annals of thoracic surgery.

[127]  D. Jacqmin,et al.  Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma , 2005, Cancer.

[128]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[129]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[130]  J. Cheville,et al.  Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. , 2004, Urology.

[131]  S. Silverman,et al.  Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. , 2004, AJR. American journal of roentgenology.

[132]  J. Patard,et al.  Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[133]  J. Lam,et al.  Changing concepts in the surgical management of renal cell carcinoma. , 2004, European urology.

[134]  Y. Neuzillet,et al.  Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. , 2004, The Journal of urology.

[135]  G. Israel,et al.  Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. , 2004, Radiology.

[136]  S. Loening,et al.  Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  J. Cheville,et al.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. , 2004, The Journal of urology.

[138]  W. Lehmacher,et al.  Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial , 2004, The Lancet.

[139]  O. Cussenot,et al.  [Hereditary forms of kidney cancer and genetic screening]. , 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[140]  R. Figlin,et al.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. , 2003, The Urologic clinics of North America.

[141]  G. Israel,et al.  Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). , 2003, AJR. American journal of roentgenology.

[142]  R. Figlin,et al.  Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  Mihir M Desai,et al.  Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. , 2003, The Journal of urology.

[144]  M. Ladanyi,et al.  Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay , 2003, The American journal of surgical pathology.

[145]  F. Rybicki,et al.  Percutaneous Biopsy of Renal Masses: Sensitivity and Negative Predictive Value Stratified by Clinical Setting and Size of Masses , 2003 .

[146]  J. Manola,et al.  Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[148]  J. Varghese,et al.  Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? , 2003, AJR. American journal of roentgenology.

[149]  D. Delakas,et al.  Nephron-sparing surgery for localized renal cell carcinoma with a normal contralateral kidney: a European three-center experience. , 2002, Urology.

[150]  J. Cheville,et al.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.

[151]  A. Nassir,et al.  Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. , 2002, Urology.

[152]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[153]  N. Munshi,et al.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.

[154]  R. Sylvester,et al.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.

[155]  B. Delahunt,et al.  Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. , 2001, Human pathology.

[156]  R. Figlin,et al.  Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  P. Boracchi,et al.  Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[158]  A. Weaver,et al.  Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. , 2000, Mayo Clinic proceedings.

[159]  O. Cussenot,et al.  [Genetics and urology]. , 2000, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[160]  M. Nishikido,et al.  Outcome of surgery in cystic renal cell carcinoma. , 2000, Urology.

[161]  R. Figlin,et al.  Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. , 2000, The Journal of urology.

[162]  A. Novick,et al.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.

[163]  D. Jacqmin,et al.  Radical Nephrectomy with and without Lymph Node Dissection: Preliminary Results of the EORTC Randomized Phase III Protocol 30881 , 1999, European Urology.

[164]  Alamdari,et al.  Follow‐up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy , 1999, BJU international.

[165]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[166]  M. Burt,et al.  Resection of metastatic renal cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[167]  E. Ritz,et al.  Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[168]  O. Cussenot,et al.  [Familial forms of cancer of the urogenital tract: clinical and genetic features]. , 1996, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[169]  F. Jolesz,et al.  Interactive MR-guided biopsy in an open-configuration MR imaging system. , 1995, Radiology.

[170]  P. Choyke,et al.  Original Articles: Kidney Cancer: Parenchymal Sparing Surgery in Patients With Hereditary Renal Cell Carcinoma , 1995 .

[171]  C. Slywotzky,et al.  Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass , 1994, Abdominal Imaging.

[172]  B. Coughlin,et al.  Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy. , 1993, AJR. American journal of roentgenology.

[173]  G. H. Weiss,et al.  The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. , 1992, AJR. American journal of roentgenology.

[174]  A. Novick,et al.  Long-term followup after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. , 1992, The Journal of urology.

[175]  P. Choyke,et al.  Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus , 1991, Human Genetics.

[176]  D. Hartman,et al.  Cystic renal cell carcinoma. , 1986, Urology.

[177]  D. Feigin,et al.  Multilocular cystic nephroma: a radiographic-pathologic correlation of 58 patients. , 1983, Radiology.

[178]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[179]  Monish Aron,et al.  800 Laparoscopic partial nephrectomies: a single surgeon series. , 2010, The Journal of urology.

[180]  P. Rehak,et al.  External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. , 2010, European urology.

[181]  M. Rouprêt,et al.  Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. , 2009, The Journal of urology.

[182]  D. Jacqmin,et al.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. , 2009, European urology.

[183]  R. Pollock,et al.  Laparoscopic radical nephrectomy for patients with pathologic T3b renal-cell carcinoma: the Johns Hopkins experience. , 2009, Journal of endourology.

[184]  Paul Russo,et al.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? , 2009, The Journal of urology.

[185]  B. Röhrig,et al.  Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm. , 2008, The Journal of urology.

[186]  A. Ravaud,et al.  Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[187]  C. Wood.  Adjuvant approaches to renal cell carcinoma. , 2008, Clinical advances in hematology & oncology : H&O.

[188]  M. Kattan,et al.  A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. , 2005, The Journal of urology.

[189]  N. Terada,et al.  The natural history of simple renal cysts. , 2002, The Journal of urology.

[190]  G. Wolf,et al.  Leptin and renal disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[191]  R. Motzer,et al.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[192]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[193]  H. Herr,et al.  Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. , 1999, The Journal of urology.

[194]  E. Fishman,et al.  Spiral computed tomography evaluation of the kidneys: state of the art. , 1998, Urology.

[195]  M. Blute,et al.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. , 1996, The Journal of urology.

[196]  M. Bosniak,et al.  The current radiological approach to renal cysts. , 1986, Radiology.